| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13107-089-01 | 13107-089 | HUMAN PRESCRIPTION DRUG | Methadone Hydrochloride | Methadone Hydrochloride | TABLET | ORAL | 20150915 | N/A | ANDA | ANDA203502 | Aurolife Pharma, LLC | METHADONE HYDROCHLORIDE | 10 mg/1 | 100 TABLET in 1 BOTTLE (13107-089-01) |
| 13107-089-30 | 13107-089 | HUMAN PRESCRIPTION DRUG | Methadone Hydrochloride | Methadone Hydrochloride | TABLET | ORAL | 20150915 | N/A | ANDA | ANDA203502 | Aurolife Pharma, LLC | METHADONE HYDROCHLORIDE | 10 mg/1 | 30 TABLET in 1 BOTTLE (13107-089-30) |
| 13107-089-99 | 13107-089 | HUMAN PRESCRIPTION DRUG | Methadone Hydrochloride | Methadone Hydrochloride | TABLET | ORAL | 20150915 | N/A | ANDA | ANDA203502 | Aurolife Pharma, LLC | METHADONE HYDROCHLORIDE | 10 mg/1 | 1000 TABLET in 1 BOTTLE (13107-089-99) |
| 13107-088-99 | 13107-088 | HUMAN PRESCRIPTION DRUG | Methadone Hydrochloride | Methadone Hydrochloride | TABLET | ORAL | 20150915 | N/A | ANDA | ANDA203502 | Aurolife Pharma, LLC | METHADONE HYDROCHLORIDE | 5 mg/1 | 1000 TABLET in 1 BOTTLE (13107-088-99) |
| 13107-088-30 | 13107-088 | HUMAN PRESCRIPTION DRUG | Methadone Hydrochloride | Methadone Hydrochloride | TABLET | ORAL | 20150915 | N/A | ANDA | ANDA203502 | Aurolife Pharma, LLC | METHADONE HYDROCHLORIDE | 5 mg/1 | 30 TABLET in 1 BOTTLE (13107-088-30) |
| 13107-088-01 | 13107-088 | HUMAN PRESCRIPTION DRUG | Methadone Hydrochloride | Methadone Hydrochloride | TABLET | ORAL | 20150915 | N/A | ANDA | ANDA203502 | Aurolife Pharma, LLC | METHADONE HYDROCHLORIDE | 5 mg/1 | 100 TABLET in 1 BOTTLE (13107-088-01) |